Skip to content

Registry for Longitudinal Evaluation of Heart Transplanted Patients

Registry for Longitudinal Evaluation of Heart Transplanted Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07431814
Enrollment
60
Registered
2026-02-25
Start date
2018-06-28
Completion date
2023-12-29
Last updated
2026-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Transplant

Keywords

heart transplant

Brief summary

The overall objective of compiling this registry is to obtain a complete collection of data, in a dedicated database, on all patients who have undergone transplantation at our Center in order to assess the main causes of mortality, hospitalization, and morbidity.

Detailed description

Secondary objective: the information acquired will enable us to review more appropriate outpatient management of these patients and redefine our internal management protocols in order to reduce morbidity, hospitalization, and mortality in these patients.

Interventions

None listed

Sponsors

Fondazione IRCCS Policlinico San Matteo di Pavia
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

\- To be included in the study the patient must: * Give written informed consent to participate for the prospective evaluations * Be a heart transplanted patient * Be aged 18 years and over

Exclusion criteria

* Withdrawn of the consent

Design outcomes

Primary

MeasureTime frameDescription
Overall Mortality in Heart Transplant RecipientsAfter 1 month, 6 months, one year, and 5 yearsThe primary objective of this registry is to evaluate overall mortality of the cohort of heart transplanted patients at Fondazione IRCCS Policlinico San Matteo.

Secondary

MeasureTime frameDescription
Cause-Specific Mortality, Morbidity, and HospitalizationAfter 1 month, 6 months, one year, and 5 yearsThe secondary objective is to evaluate the specific mortality, morbidity and hospitalization

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026